Of note, the progressive loss of ACE2 in COVID-19 shifts the system to an overall higher angiotensin level due to the impaired ability of ACE2 to degrade it, which may explain the hemodynamic stability during the initial stages of the disease [64]. The gene discussed is ACE2; the disease is COVID-19.